Patents by Inventor Nora Torres-Nagel

Nora Torres-Nagel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AUTOMATED PLATFORMS FOR PREPARATION OF BIOMARKER AND ROMANOWSKY-TYPE STAINED SAMPLE PRINTED ON A SLIDE
    Publication number: 20230221316
    Abstract: The present disclosure relates generally to methods and systems for detecting, characterizing biomarker expression and morphological analysis in cell samples. The methods allow for the use of automated platforms to stain cells for molecular biomarkers and Romanowsky-type staining for cell morphology analysis. Cells that are prepared according to the disclosed methods can also be used in the diagnosis of certain conditions.
    Type: Application
    Filed: May 19, 2021
    Publication date: July 13, 2023
    Inventors: Anna Maria NEUBAUER-PERCHUC, Jan-Gerrit HOOGENDIJK, Nicole GRETHER, David J. ZAHNISER, Katherine K. MUI, Michael TACKE, Nora TORRES-NAGEL
  • Antibodies against human EPO receptor
    Patent number: 9221909
    Abstract: An antibody binding to human EPO-R, characterized in specifically binding pY461, pY430 or p465 is useful for the determination of activated EPO receptor.
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: December 29, 2015
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Jarsch, Manfred Kubbies, Olaf Mundigl, Nora Torres-Nagel
  • ANTIBODIES AGAINST HUMAN EPO RECEPTOR
    Publication number: 20120122120
    Abstract: An antibody binding to human EPO-R, characterized in specifically binding pY461, pY430 or p465 is useful for the determination of activated EPO receptor.
    Type: Application
    Filed: January 13, 2010
    Publication date: May 17, 2012
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Michael Jarsch, Manfred Kubbies, Olaf Mundigl, Nora Torres-Nagel
  • ANTIBODIES AGAINST HUMAN EPO RECEPTOR
    Publication number: 20110165592
    Abstract: An antibody binding to human EPO receptor, characterized in specifically binding EPO receptor fragment LDKWLLPRNPPSEDLPGPGGSVDIV (SEQ ID NO:1), CSSALASKPSPEGASAASFEY (SEQ ID NO:2), or GGLSDGPYSNPYENSLIPAAEP (SEQ ID NO:3) is useful for the analysis of EPO receptor in human tissue.
    Type: Application
    Filed: August 28, 2009
    Publication date: July 7, 2011
    Applicant: Hoffman-La Roche. Inc.
    Inventors: Michael Jarsch, Manfred Kubbies, Olaf Mundigl, Nora Torres-Nagel
  • ANTIBODIES AGAINST HUMAN EPO RECEPTOR
    Publication number: 20110143372
    Abstract: An antibody binding to human EPO receptor, characterized in specifically binding EPO receptor fragment LDKWLLPRNPPSEDLPGPGGSVDIV (SEQ ID NO:1), CSSALASKPSPEGASAASFEY (SEQ ID NO:2), or GGLSDGPYSNPYENSLIPAAEP (SEQ ID NO:3) is useful for the analysis of EPO receptor in human tissue.
    Type: Application
    Filed: February 25, 2011
    Publication date: June 16, 2011
    Applicant: Hoffman-La Roche, Inc.
    Inventors: Michael Jarsch, Manfred Kubbies, Olaf Mundigl, Nora Torres-Nagel